Clinical Trials

VERiTAS- Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke Study (VERiTAS)

  • International multicenter $2million NIH funded R01 grant
  • PI: Sepideh Amin-Hanjani, MD
  • Project Manger: Linda Rose-Finnell, MPA, CRA
  • UIC is the coordinating center and 1 of the 6 sites



  • Single Site Healthy Volunteers
  • PI: Fady T. Charbel, MD
  • Looking for healthy volunteers –have over 300 volunteers at present, current focus is over 60 year old.
  • More details on the NOVA technology are available at


A Prospective Multicenter Trial of Novo-TTF-100A together with Temozolomide alone in patients with newly diagnosed GBM (EF-14)

  • International, multisite study looking at patients with newly diagnosed stage IV brain tumors, glioblastoma multiforme (GBM)
  • UIC PI: Herbert Engelhard, MD, PhD
  • Sponsor, Novocure, Ltd.


A prospective, non-randomized, concurrent control, open label, post-approval study of NovoTTF-100A in recurrent GBM patients (EF-19)

  • To confirm that the efficacy of the NovoTTF-100A System in patients with recurrent GBM treated in a real life setting is comparable to that of BSC chemotherapy patients.
  • UIC PI: Herbert Engelhard, MD, PhD
  • Sponsor, Novocure, Ltd.


ISPR Study Implantable System Performance Registry (ISPR)

  • Postmarket surveillance registry initiated by Medtronic (sponsor) to obtain long-term follow-up data on all Medtronic implantable infusion and neurostimulation systems implanted at UIC in order to prospectively monitor the performance of such systems
  • UIC PI: Konstantin Slavin


Neurosurgery Brain Tumor Registry, NBTR

  • Collaboration with Department of Neuro-Oncology to create a database will all patients seen in the Dept of Neurosurgery and Oncology diagnosed with either primary or secondary brain tumor.
  • UIC PI: Herbert Engelhard, MD, PhD
  • Sponsored by the Department of Neurosurgery


Reclaim Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD) Therapy

  • The Reclaim DBS System delivers electrical stimulation to the area in the brain to help control symptoms of obsessive compulsive disorder (OCD).
  • UIC PI: Konstantin Slavin, MD
  • Sponsor, Medtronic, Inc.


Prospective, multi-center, randomized, double-blinded, partial crossover study to assess the safetyand efficacy of the bioness® stimrouter™ neuromodulation system in the treatment for patients with chronic pain of peripheral nerve origin

  • To investigate whether the StimRouter stimulation therapy leads to clinically relevant pain relief in patients with chronic intractable pain of peripheral nerve origin after 3 months of treatment.
  • UIC PI: Konstantin Slavin, MD
  • Sponsor, Bioness, Inc.


ACE: An Aneurysm Coiling Efficiency Study of the Penumbra Coil 400 System

  • This study is a prospective, multi-center study of patients with intracranial  aneurysms, peripheral aneurysms or other malformations who are treated by the PC 400 System.
  • UIC PI: Victor Aletich, MD
  • Sponsor, Penumbra, Inc.